WallStSmart

Northrop Grumman Corporation (NOC)vsQXO, Inc. (QXO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Northrop Grumman Corporation generates 519% more annual revenue ($42.37B vs $6.84B). NOC leads profitability with a 10.8% profit margin vs -4.1%. QXO appears more attractively valued with a PEG of 2.88. NOC earns a higher WallStSmart Score of 63/100 (C+).

NOC

Buy

63

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 3.3Quality: 4.5
Piotroski: 3/9Altman Z: 1.96

QXO

Hold

48

out of 100

Grade: D+

Growth: 8.0Profit: 2.5Value: 3.0Quality: 4.8
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NOCSignificantly Overvalued (-61.6%)

Margin of Safety

-61.6%

Fair Value

$419.98

Current Price

$579.48

$159.50 premium

UndervaluedFair: $419.98Overvalued
QXOSignificantly Overvalued (-17.0%)

Margin of Safety

-17.0%

Fair Value

$23.12

Current Price

$19.61

$3.51 premium

UndervaluedFair: $23.12Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NOC3 strengths · Avg: 9.3/10
EPS GrowthGrowth
84.9%10/10

Earnings expanding 84.9% YoY

Market CapQuality
$82.31B9/10

Large-cap with strong market position

Return on EquityProfitability
28.5%9/10

Every $100 of equity generates 29 in profit

QXO2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
14725.0%10/10

Revenue surging 14725.0% year-over-year

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Areas to Watch

NOC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Debt/EquityHealth
1.183/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

QXO4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
2.882/10

Expensive relative to growth rate

Return on EquityProfitability
-3.8%2/10

ROE of -3.8% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : NOC

The strongest argument for NOC centers on EPS Growth, Market Cap, Return on Equity.

Bull Case : QXO

The strongest argument for QXO centers on Revenue Growth, Price/Book. Revenue growth of 14725.0% demonstrates continued momentum.

Bear Case : NOC

The primary concerns for NOC are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : QXO

The primary concerns for QXO are EPS Growth, Piotroski F-Score, PEG Ratio.

Key Dynamics to Monitor

NOC profiles as a value stock while QXO is a hypergrowth play — different risk/reward profiles.

QXO carries more volatility with a beta of 2.47 — expect wider price swings.

QXO is growing revenue faster at 14725.0% — sustainability is the question.

QXO generates stronger free cash flow (158M), providing more financial flexibility.

Bottom Line

NOC scores higher overall (63/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Northrop Grumman Corporation

INDUSTRIALS · AEROSPACE & DEFENSE · USA

Northrop Grumman Corporation (NYSE: NOC) is an American multinational aerospace and defense technology company.

Visit Website →

QXO, Inc.

INDUSTRIALS · INDUSTRIAL DISTRIBUTION · USA

QXO, Inc. is a business application, technology, and consulting company in North America. The company is headquartered in Greenwich, Connecticut.

Want to dig deeper into these stocks?